Hypercaloric, hyperproteic oral supplement

Hypercaloric, hyperproteic oral supplement has been studied in 1 paper since 2023: 1 trial in people. The newest paper, Dec 28, 2023: “Mediterranean Diet, Vitamin D, and Hypercaloric, Hyperproteic Oral Supplements for Treating Sarcopenia in Patients with Heart Failure-A Randomized Clinical Trial”.

Intervention

1 paper studies it4 findingsUpdated

See all 1 papers on hypercaloric, hyperproteic oral supplement

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“lean mass, and body mass increased in the intervention group (absolute increase of 0.5, p = 0.03, 1.2 kg, p = 0.03, and 0.1 kg, p = 0.03 respectively)”
Mediterranean Diet, Vitamin D, and Hypercaloric, Hyperproteic Oral Supplements for Treating Sarcopenia in Patients with Heart Failure-A Randomized Clinical TrialNutrients2023doi:10.3390/nu16010110

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Funder: Instituto de Salud Carlos III
  • Human trial1

Studies in people

1 study gave hypercaloric, hyperproteic oral supplement to people and measured what changed.

What changedDesignPeopleSource

up: Increases muscle mass55.3 kg (50.1–61.1) at the end of the study vs. 52.5 kg (49.8–60.9) at baseline

down: Decreases NT-proBNPdecreased by 1303 pg/mL (741–2111) after 24 weeks

Randomized trialtwenty-four weeks38 peopleMost of them were male (71.1%)median age of 67.5 y-oldPatients with heart failure and LVEF < 50%Nutrients, Dec 28, 2023

What did studies of hypercaloric, hyperproteic oral supplement find?

2

Studies of hypercaloric, hyperproteic oral supplement measured 2 outcomes: NT-proBNP and muscle mass.

NT-proBNP

downin humans1

1 study
  1. Hypercaloric, hyperproteic oral supplement decreases NT-proBNP in humans (plus Mediterranean diet) (decreased by 1303 pg/mL (741–2111) after 24 weeks).

    “In particular, the intervention group (1952 pg/mL (1179–3307 at baseline) decreased by 1303 pg/mL (741–2111) after 24 weeks (p = 0.02). Although NT-proBNP also decreased in the control group, this change was not statistically significant.”

    Human trialplus Mediterranean diettwenty-four weeksn = 19

    Mediterranean Diet, Vitamin D, and Hypercaloric, Hyperproteic Oral Supplements for Treating Sarcopenia in Patients with Heart Failure-A Randomized Clinical Trial

    Nutrients

  2. Hypercaloric, hyperproteic oral supplement decreases NT-proBNP in patients with heart failure.

    “Serum values of NT-proBNP also significantly decreased in the whole cohort (p < 0.01), especially in the intervention group (p = 0.02)”

    Human trialin patients with heart failure24 weeksn = 38

    Mediterranean Diet, Vitamin D, and Hypercaloric, Hyperproteic Oral Supplements for Treating Sarcopenia in Patients with Heart Failure-A Randomized Clinical Trial

    Nutrients

More on NT-proBNP

Muscle mass

upin humans1

1 study
  1. Hypercaloric, hyperproteic oral supplement increases muscle mass in humans (plus Mediterranean diet) (55.3 kg (50.1–61.1) at the end of the study vs. 52.5 kg (49.8–60.9) at baseline).

    “When lean mass was analyzed, it significantly increased in the intervention group (55.3 kg (50.1–61.1) at the end of the study vs. 52.5 kg (49.8–60.9) at baseline, p = 0.03).”

    Human trialplus Mediterranean diettwenty-four weeksn = 19

    Mediterranean Diet, Vitamin D, and Hypercaloric, Hyperproteic Oral Supplements for Treating Sarcopenia in Patients with Heart Failure-A Randomized Clinical Trial

    Nutrients

  2. Hypercaloric, hyperproteic oral supplement increases muscle mass in patients with heart failure (+1.2 kg).

    “lean mass, and body mass increased in the intervention group (absolute increase of 0.5, p = 0.03, 1.2 kg, p = 0.03, and 0.1 kg, p = 0.03 respectively)”

    Human trialin patients with heart failuretwenty-four weeksn = 38

    Mediterranean Diet, Vitamin D, and Hypercaloric, Hyperproteic Oral Supplements for Treating Sarcopenia in Patients with Heart Failure-A Randomized Clinical Trial

    Nutrients

Latest